Fig. 3From: A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov modelCost effectiveness plane showing the plots of ICERs generated from simulationBack to article page